Afficher la notice abrégée

dc.contributor.authorDouglas, Thomas
dc.contributor.authorD. Earp, Brian
dc.contributor.authorSavulescu, Julian
dc.date.accessioned2021-02-10T12:58:18Z
dc.date.issued2018
dc.date.submitted2019-10-18 14:17:05
dc.date.submitted2020-04-01T13:03:18Z
dc.date.submitted2018-02-28 23:55
dc.date.submitted2019-10-18 14:17:05
dc.date.submitted2020-04-01T13:03:18Z
dc.date.submitted2018-02-01 23:55:55
dc.date.submitted2019-10-18 14:17:05
dc.date.submitted2020-04-01T13:03:18Z
dc.identifier644654
dc.identifierOCN: 1030820993
dc.identifierhttp://library.oapen.org/handle/20.500.12657/30625
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/34620
dc.description.abstractIn recent years, philosophers, neuroethicists, and others have become preoccupied with “moral enhancement.” Very roughly, this refers to the deliberate moral improvement of an individual’s character, motives, or behavior. In one sense, such enhancement could be seen as “nothing new at all” (Wiseman, 2016, 4) or as something philosophically mundane: as G. Owen Schaefer (2015) has stated, “Moral enhancement is an ostensibly laudable project. . . .
dc.languageEnglish
dc.rightsopen access
dc.subject.othermotives
dc.subject.othermoral improvement
dc.subject.otherbehaviour
dc.subject.othercharacter
dc.subject.otherindividuals
dc.subject.othermotives
dc.subject.othermoral improvement
dc.subject.otherbehaviour
dc.subject.othercharacter
dc.subject.otherindividuals
dc.subject.otherAkrasia
dc.subject.otherAugmentative
dc.subject.otherEmpathy
dc.subject.otherEthics
dc.subject.otherMorality
dc.subject.otherMos maiorum
dc.subject.otherNeuroenhancement
dc.subject.otherNeurotechnology
dc.subject.otherPsilocybin
dc.subject.otherthema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBP Health systems and services::MBPK Mental health services
dc.titleChapter 11 Moral Neuroenhancement
dc.typechapter
oapen.relation.isPublishedByfa69b019-f4ee-4979-8d42-c6b6c476b5f0
oapen.relation.isPartOfBookThe Routledge handbook of neuroethics
oapen.relation.isFundedByWellcome Trust
oapen.relation.isbn9781315708652
oapen.collectionWellcome
oapen.imprintRoutledge
oapen.pages21
oapen.review.commentsTaylor & Francis open access titles are reviewed as a minimum at proposal stage by at least two external peer reviewers and an internal editor (additional reviews may be sought and additional content reviewed as required).
peerreview.review.typeProposal
peerreview.anonymitySingle-anonymised
peerreview.reviewer.typeInternal editor
peerreview.reviewer.typeExternal peer reviewer
peerreview.review.stagePre-publication
peerreview.open.reviewNo
peerreview.publish.responsibilityPublisher
peerreview.idbc80075c-96cc-4740-a9f3-a234bc2598f1
dc.relationisFundedByd859fbd3-d884-4090-a0ec-baf821c9abfd
dc.chapternumber1
peerreview.titleProposal review


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

open access
Excepté là où spécifié autrement, la license de ce document est décrite en tant que open access